FY2025 · period end Jun '25 · from the 10-K filed Aug 11, 2025
| Metric | FY25Jun '25 | FY24Jun '24 | FY23Jun '23 | FY22Jun '22 | FY21Jun '21 |
|---|---|---|---|---|---|
| Revenue | $18.44B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 10-Q | 0000707549-26-000022 | Mar 29, 2026 | Apr 23, 2026 | Apr 23, 2026 20:05 UTC | EDGAR |
| 8-K | 0000707549-26-000020 | Apr 22, 2026 | Apr 22, 2026 | Apr 22, 2026 20:09 UTC | EDGAR |
| 8-K | 0000707549-26-000012 | Jan 30, 2026 | Feb 3, 2026 | Feb 3, 2026 21:13 UTC | EDGAR |
| 10-Q | 0000707549-26-000009 | Dec 28, 2025 | Jan 29, 2026 | Jan 29, 2026 21:16 UTC | EDGAR |
| 8-K | 0000707549-26-000006 | Jan 28, 2026 | Jan 28, 2026 | Jan 28, 2026 21:06 UTC | EDGAR |
| 8-K | 0000707549-25-000094 | Nov 4, 2025 | Nov 6, 2025 | Nov 6, 2025 21:02 UTC | EDGAR |
| 10-Q | 0000707549-25-000085 | Sep 28, 2025 | Oct 24, 2025 | Oct 24, 2025 20:06 UTC | EDGAR |
| 8-K | 0000707549-25-000082 | Oct 22, 2025 | Oct 22, 2025 | Oct 22, 2025 20:08 UTC | EDGAR |
Direct links to SEC EDGAR. LRCX has additional filings available on the SEC site.
6 numbers LAM RESEARCH CORP later changed — same XBRL tag, both filings linked.
Long-term Debt, Excluding Current Maturities·As of Jun 24, 2012
Major restatementwas$900M
Revised down in a 10-K.
Liabilities, Current·As of Jun 26, 2011
Minor restatementwas$684.3M
Revised down in a 10-K.
Common Stock, Value, Issued·As of Jun 30, 2024
Major restatementwas$130K
Revised up in a 10-K.
Other Noncash Income (Expense)·FY 2020
Major restatementwas-$688K
Revised down in a 10-K.
OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax·FY 2011
Major restatementwas$621K
Revised down in a 10-K.
Other Noncash Income (Expense)·Q3 2021
Major restatementwas-$6.1M
Revised down in a 10-Q.
LRCX is not the only one.
See every restatement we've found across the market — or get an alert the next time LRCX revises a number.
Restatements are detected by comparing every vintage of a fact across all of LAM RESEARCH CORP's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows LRCX's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling LAM RESEARCH CORP — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on LRCX yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on LRCX and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $17.43B |
| $17.23B |
| $14.63B |
| Gross Profit | $8.98B | $7.05B | $7.78B | $7.87B | $6.81B |
|---|
| Operating Income | $5.90B | $4.26B | $5.17B | $5.38B | $4.48B |
|---|
| Net Income | $5.36B | $3.83B | $4.51B | $4.61B | $3.91B |
|---|
| EPS (Diluted) | $4.15 | $2.90 | $3.32 | $32.75 | $26.90 |
|---|
| Metric | FY25Jun '25 | FY24Jun '24 | FY23Jun '23 | FY22Jun '22 | FY21Jun '21 |
|---|---|---|---|---|---|
| Total Assets | $21.35B | $18.74B | $18.78B | $17.20B | $15.89B |
| Total Liabilities | $11.48B | $10.21B | $10.57B | $10.92B | $9.86B |
| Stockholders' Equity | $9.86B | $8.54B | $8.21B | $6.28B | $6.03B |
| Cash & Equivalents | $6.39B | $5.85B | $5.34B | $3.77B | $4.67B |
| Total Debt | $3.73B | $4.48B | $5.00B | $5.00B | $4.99B |
| Metric | FY25Jun '25 | FY24Jun '24 | FY23Jun '23 | FY22Jun '22 | FY21Jun '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $6.17B | $4.65B | $5.18B | $3.10B | $3.59B |
| Capital Expenditures | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — |
| Metric | FY25Jun '25 | FY24Jun '24 | FY23Jun '23 | FY22Jun '22 | FY21Jun '21 |
|---|---|---|---|---|---|
| Gross Margin | 48.7% | 47.3% | 44.6% | 45.7% | 46.5% |
| Operating Margin | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% |
| Net Margin | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% |
| Return on Equity | 58.2% | 44.8% | 62.3% | 74.8% | 69.8% |
| Return on Assets | 26.7% | 20.4% | 25.1% | 27.8% | 25.7% |
| Debt / Equity | 0.46× | 0.52× | 0.61× | 0.80× | 0.83× |
